Oppenheimer lowered the firm’s price target on Acrivon Therapeutics (ACRV) to $10 from $18 and keeps an Outperform rating on the shares ...

A popular theory frequently utilized by technical analysts suggests U.S. stocks could be headed for one last leg higher over ...

Oppenheimer maintained its Outperform rating on AppLovin (NASDAQ:APP) while highlighting key points for the company from the ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

Meeting to be held on April 1 hosted by Oppenheimer.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

Oppenheimer said on Wednesday it no longer expects growth in U.S. investment banking revenue this year and slashed its ...

Oppenheimer called the expected M&A rebound under the Trump administration “delayed or cancelled” and downgraded to "perform" ...

The pioneering physicist’s moral worldview and politics were shaped by a complicated relationship with his Jewishness and a hatred of the Nazis. (JTA) — Friday is not just “Barbie” release ...

Written and Directed by Joshua Oppenheimer. Starring Tilda Swinton, George MacKay, Moses Ingram, Michael Shannon, Bronagh ...

Christopher Nolan doesn't need an image to maintain; from Following (1998) to Oppenheimer (2023), fans know what's in store ...

Oppenheimer began coverage on shares of Aurora Innovation (NASDAQ:AUR – Free Report) in a report released on Thursday morning ...

Oppenheimer upgraded The Mosaic Company (NYSE:MOS) to Outperform from Perform and set a price target of $33 given the fertilizer maker’s efforts to reduce costs, optimize its product portfolio, and ...